6 Blackhall FH, Merry CL, Lyon M, Jayson GC, Folkman J, Javaherian K, Gallagher JT.Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. Biochem J 2003;375(Pt 1):131139
7 Ding YH, Javaherian K, Lo KM, Chopra R, Boehm T, Lanciotti J, Harris BA, Li Y, Shapiro R, Hohenester E, Timpl R, Folkman J, Wiley DC. Zincdependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci U S A 1998;95(18):1044310448
8 Yamaguchi N, AnandApte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR. Endostatin inhibits VEGFinduced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 1998;18(16):44144423
9 Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG. Endostatin blocks vascular endothelial growth factormediated signaling via direct interaction with KDR/Flk1. J Biol Chem 2002;277(31):2787227879
10 Rehn M, Veikkola T, KukkValdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001;98(3):10241029
11 Javaherian K, Park SY, Pickl WF, LaMontagne KR, Sjin RT, Gillies S, Lo KM. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J Biol Chem 2002;277(47):4521145218
12 Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007;110(8):28992906
13 Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R, Sukhatme VP. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 2002;277(19):1646416469
14 Li WY, Gao XW, Ren B. Endostatin and ocular neovascularization. Int J Ophthalmol(Guoji Yanke Zazhi) 2007;7(5):13931395
15 Campochiaro PA.Gene therapy for ocular neovascularization. Curr Gene Ther 2007;7(1):2533
16 Lai LJ, Xiao X, Wu JH. Inhibition of corneal neovascularization with endostatin delivered by adenoassociated viral (AAV) vector in a mouse corneal injury model. J Biomed Sci 2007;14(3):313322
17 Zhang P, Wu DZ, Yue T, Zhu ZY, Lin JX, Feng GG, Zheng HL. Inhibition of corneal neovascularization by endostatin gene transfection in rats. Int J Ophthalmol(Guoji Yanke Zazi) 2004;4(1):6065
18 Veronese FM, Harris JM. Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 2002;54(4):453456
19 Li ZN, Mu GY, Yuan ZF. An experimental study of antiangiogenesis with polyethylene glycol endostatin. J Ocular Trauma Occupational Eye Disease 2007;29(4):241244
20 Tan H, Yang S, Feng Y, Liu C, Cao J, Mu G, Wang F. Characterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparin. J Biochem 2008;144(2):207213
21 Zhu W, Tao XC, Li X. Modification of endostatin with low molecular weight heparin and its angiogenesis effects on rabbit corneas. J Otolaryngol Opthal Shandong UNIV 2007;21(5)471473
22 Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. Int J Cancer 2002;101(3):224234
23 Meyer A, Auernheimer J, Modlinger A, Kessler H. Targeting RGD recognizing integrins: drug development, biomaterial research,tumor imaging and targeting. Curr Pharm Des 2006;12(22):27232747
24 Yokoyama Y, Ramakrishnan S. Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth. Int J Cancer 2004;111(6):839848
25 Ren MH, Wang SJ, Lin XS. Structural Modification and Antitumor Activity Change of Recombinant Human Endostatin. J Biochemistry and Molecular Biology 2005;21(1):4552
26 Yokoyama Y, Ramakrishnan S. Addition of an aminopeptidase Nbinding sequence to human endostatin improves inhibition of ovarian carcinoma growth. Cancer 2005;104(2):321331
27 Song HF, Liu XW, Zhang HN, Zhu BZ, Yuan SJ, Liu SY, Tang ZM. Pharmacokinetics of Histag recombinant human endostatin in Rhesus monkeys. Acta Pharmacol Sin 2005;26(1):124128
28 Ling Y, Yang Y, Lu N, You QD, Wang S, Gao Y, Chen Y, Guo QL. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGFinduced tyrosine phosphorylation of KDR /Flk21 of endothelial cells. Biochem Biophys Res Commun 2007;361(1):7984
上一页 [1] [2] [3] |